Product Information
GNP NASAL FOUR 1% NASAL SPRAY is a generic product labeled by AmerisourceBergen, priced at $0.0842 per ML under NDC 46122068903. Its NADAC has been published 242 times since Oct 13, 2021.
Strength
1 g/100mL
Manufacturer
AmerisourceBergenNDC
46122068903
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Effective Date
5/20/2026
Active Ingredients
PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/15/2021
Pharmacological Classes
Price Statistics
The NADAC for GNP NASAL FOUR 1% NASAL SPRAY has been published 242 times since Oct 13, 2021, and over the history we have for it it has risen 11.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0842 per ML |
|---|---|
| All-time high | $0.0874 (Mar 15, 2023) |
| All-time low | $0.0721 (Oct 23, 2024) |
| 52-week high | $0.0842 |
| 52-week low | $0.0811 |
| Median price | $0.0817 |
| Average price | $0.0802 |
| Largest weekly change | +13.6% (Jan 17, 2024) |
| Weeks tracked | 242 |
| Tracking since | Oct 13, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.9%
1Y
+3.9%
3Y
+12.4%
5Y
N/A
All
+11.1%
Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phenylephrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP NASAL FOUR 1% NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for GNP NASAL FOUR 1% NASAL SPRAY, manufactured by AmerisourceBergen, is $0.0842 per ML (NDC 46122068903), effective May 27, 2026.
How has the price of GNP NASAL FOUR 1% NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for GNP NASAL FOUR 1% NASAL SPRAY has risen 11.1%. It has been tracked across 242 weekly CMS publications since Oct 13, 2021.
What are the highest and lowest recorded NADAC prices for GNP NASAL FOUR 1% NASAL SPRAY?
Since Oct 13, 2021, the NADAC for GNP NASAL FOUR 1% NASAL SPRAY has ranged from a low of $0.0721 (Oct 23, 2024) to a high of $0.0874 (Mar 15, 2023), with a median of $0.0817 per ML.
Are there cheaper alternatives to GNP NASAL FOUR 1% NASAL SPRAY?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NASAL FOUR 1% NASAL SPRAY, is $0.0623 per ML — about 26% below GNP NASAL FOUR 1% NASAL SPRAY.
Who manufactures GNP NASAL FOUR 1% NASAL SPRAY?
GNP NASAL FOUR 1% NASAL SPRAY (NDC 46122068903) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.